183 related articles for article (PubMed ID: 24275103)
1. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH
Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
[TBL] [Abstract][Full Text] [Related]
2. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.
Khunti K; Millar-Jones D
Prim Care Diabetes; 2017 Feb; 11(1):3-12. PubMed ID: 27727005
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes.
Levin PA; Wei W; Zhou S; Xie L; Baser O
J Manag Care Spec Pharm; 2014 May; 20(5):501-12. PubMed ID: 24761822
[TBL] [Abstract][Full Text] [Related]
4. Approaches to treatment 1: How is type 2 diabetes actually treated?
Bloomgarden ZT
J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
[No Abstract] [Full Text] [Related]
5. Individualised treatment targets in patients with type-2 diabetes and hypertension.
Schmieder RE; Tschöpe D; Koch C; Ouarrak T; Gitt AK;
Cardiovasc Diabetol; 2018 Jan; 17(1):18. PubMed ID: 29357854
[TBL] [Abstract][Full Text] [Related]
6. Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial.
Manski-Nankervis JA; Furler J; O'Neal D; Ginnivan L; Thuraisingam S; Blackberry I
Prim Care Diabetes; 2017 Oct; 11(5):474-481. PubMed ID: 28705697
[TBL] [Abstract][Full Text] [Related]
7. Changes in the management of type 2 diabetic patients in family medicine practices in the Bursa region.
Göktaş O; Öz Gül Ö; Ertürk E
Prim Care Diabetes; 2017 Apr; 11(2):178-183. PubMed ID: 27852516
[TBL] [Abstract][Full Text] [Related]
8. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with Prolonged Inaction in the hypoglycaemic treatment in people with non-insulin dependent Type 2 Diabetes and elevated glycated haemoglobin: A registry-based cohort study.
Goderis G; Vaes B; Van den Akker M; Elli S; Mathieu C; Buntinx F; Henrard S
Prim Care Diabetes; 2017 Oct; 11(5):482-489. PubMed ID: 28648964
[TBL] [Abstract][Full Text] [Related]
10. Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.
Eder S; Leierer J; Kerschbaum J; Rosivall L; Wiecek A; de Zeeuw D; Mark PB; Heinze G; Rossing P; Heerspink HL; Mayer G
Diab Vasc Dis Res; 2019 Jan; 16(1):47-56. PubMed ID: 30238781
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
[TBL] [Abstract][Full Text] [Related]
12. Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice.
Khunti K; Vora J; Davies M
Prim Care Diabetes; 2014 Apr; 8(1):57-63. PubMed ID: 24378771
[TBL] [Abstract][Full Text] [Related]
13. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
Neumark AS; Brudin L; Neumark T
Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
[TBL] [Abstract][Full Text] [Related]
14. Should the last be first? Questions and dilemmas regarding early short-term insulin treatment in Type 2 Diabetes Mellitus.
Koufakis T; Karras SN; Zebekakis P; Ajjan R; Kotsa K
Expert Opin Biol Ther; 2018 Nov; 18(11):1113-1121. PubMed ID: 30244600
[TBL] [Abstract][Full Text] [Related]
15. Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up.
Wilding J; Bailey C; Rigney U; Blak B; Kok M; Emmas C
Prim Care Diabetes; 2017 Oct; 11(5):437-444. PubMed ID: 28583425
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in insulin therapy regimens in five European countries
.
Rathmann W; Czech M; Franek E; Kostev K
Int J Clin Pharmacol Ther; 2017 May; 55(5):403-408. PubMed ID: 28257286
[TBL] [Abstract][Full Text] [Related]
17. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.
Migdal A; Abrahamson M; Peters A; Vint N
Ann Med; 2018 Sep; 50(6):453-460. PubMed ID: 30103624
[TBL] [Abstract][Full Text] [Related]
18. Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010).
Kostev K; Rathmann W
Prim Care Diabetes; 2013 Oct; 7(3):229-33. PubMed ID: 23608219
[TBL] [Abstract][Full Text] [Related]
19. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm.
McCreedy EM; Kane RL; Gollust SE; Shippee ND; Clark KD
J Am Board Fam Med; 2018; 31(2):192-200. PubMed ID: 29535235
[TBL] [Abstract][Full Text] [Related]
20. The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.
Murata T; Aoki Y; Kato Y; Tanaka T; Araki R; Kato K; Hida K; Kawamura T; Yoshida K; Imamura Y; Toyonaga T; Yamada K; Sakane N;
J Diabetes Sci Technol; 2017 Sep; 11(5):1055-1056. PubMed ID: 28859515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
